Soligenix gets FDA clearance for Phase II psoriasis trial
The company plans to commence subject enrolment in the trial in the fourth quarter of this year.
United States
Latest in
United States
Swing selects Curavit as virtual site for fibromyalgia DTx trial
Curavit’s decentralised clinical trial capabilities make it ideal for prescription and non-prescription DTx studies.
A disappointing June for Alzheimer’s disease, with setbacks for several products
Several companies have announced poor results from clinical trials for Alzheimer’s disease therapies this month.
By
Ceruvia’s Phase II obsessive-compulsive disorder trial receives FDA clearance
Analysing the decline in OCD symptoms for up to 12 weeks following a single dose of SYNP-101 is the trial’s…
Kezar reports positive Phase II data of zetomipzomib for lupus nephritis
In the trial, 64.7% of the trial subjects attained an ORR, which is the primary efficacy endpoint of the study.
Medidata introduces new technologies for trial management
Visual Analytics for Rave CTMS aids users to swiftly navigate, search and merge data using intuitive visuals, charts and tables.
Prestige Biopharma receives FDA approval for Phase I/IIa pancreatic cancer trial
PBP1510 received Orphan Drug Designation from the FDA, the European Medicines Agency and Korean MFDS, in 2020.
Seasonal influenza extends later than previous seasons
The 2021–22 influenza season has had an unusually high amount of activity late in the season, with two peaks in…
By